WO2008089003A3 - System for optical stimulation of target cells - Google Patents

System for optical stimulation of target cells Download PDF

Info

Publication number
WO2008089003A3
WO2008089003A3 PCT/US2008/050628 US2008050628W WO2008089003A3 WO 2008089003 A3 WO2008089003 A3 WO 2008089003A3 US 2008050628 W US2008050628 W US 2008050628W WO 2008089003 A3 WO2008089003 A3 WO 2008089003A3
Authority
WO
WIPO (PCT)
Prior art keywords
target cells
light
methods
vivo
stimulated
Prior art date
Application number
PCT/US2008/050628
Other languages
French (fr)
Other versions
WO2008089003A2 (en
Inventor
Feng Zhang
Karl Deisseroth
David J Mishelevich
M Bret Schneider
Original Assignee
Univ Leland Stanford Junior
Feng Zhang
Karl Deisseroth
David J Mishelevich
M Bret Schneider
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/651,422 external-priority patent/US8926959B2/en
Application filed by Univ Leland Stanford Junior, Feng Zhang, Karl Deisseroth, David J Mishelevich, M Bret Schneider filed Critical Univ Leland Stanford Junior
Priority to US12/522,528 priority Critical patent/US10052497B2/en
Publication of WO2008089003A2 publication Critical patent/WO2008089003A2/en
Publication of WO2008089003A3 publication Critical patent/WO2008089003A3/en
Priority to US16/041,647 priority patent/US20180326221A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0622—Optical stimulation for exciting neural tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes

Abstract

Stimulation of target cells using light, e.g., in vivo, is implemented using a variety of methods and devices. In one example, embodiments involve methods for stimulating target cells using a photosensitive protein that allows the target cells to be stimulated in response to light. In another specific example embodiment, target cells are stimulated using an implantable arrangement. The arrangement includes an electrical light-generation means for generating light and a biological portion. The biological portion has a photosensitive bio-molecular arrangement that responds to the generated light by stimulating target cells in vivo. Other aspects and embodiments are directed to systems and methods for screening chemicals based screening chemicals to identify their effects on cell membrane ion channels and pumps, and to systems and methods for controlling an action potential of neuron (e.g., in vivo and in vitro environments).
PCT/US2008/050628 2005-07-22 2008-01-09 System for optical stimulation of target cells WO2008089003A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/522,528 US10052497B2 (en) 2005-07-22 2008-01-09 System for optical stimulation of target cells
US16/041,647 US20180326221A1 (en) 2005-07-22 2018-07-20 System for optical stimulation of target cells

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US11/651,422 2007-01-09
US11/651,422 US8926959B2 (en) 2005-07-22 2007-01-09 System for optical stimulation of target cells
US87966907P 2007-01-10 2007-01-10
US60/879,669 2007-01-10
US90430307P 2007-03-01 2007-03-01
US60/904,303 2007-03-01
US95511607P 2007-08-10 2007-08-10
US60/955,116 2007-08-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/651,422 Continuation US8926959B2 (en) 2005-07-22 2007-01-09 System for optical stimulation of target cells

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/522,528 A-371-Of-International US10052497B2 (en) 2005-07-22 2008-01-09 System for optical stimulation of target cells
US16/041,647 Continuation US20180326221A1 (en) 2005-07-22 2018-07-20 System for optical stimulation of target cells

Publications (2)

Publication Number Publication Date
WO2008089003A2 WO2008089003A2 (en) 2008-07-24
WO2008089003A3 true WO2008089003A3 (en) 2008-09-25

Family

ID=39636625

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/050628 WO2008089003A2 (en) 2005-07-22 2008-01-09 System for optical stimulation of target cells

Country Status (1)

Country Link
WO (1) WO2008089003A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858440B2 (en) 2008-07-14 2014-10-14 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and devices for modulating cellular activity using ultrasound
US9042201B2 (en) 2011-10-21 2015-05-26 Thync, Inc. Method and system for direct communication
CN107531765B (en) * 2015-03-19 2021-07-16 得克萨斯州大学系统董事会 Compositions of anion channel rhodopsin and methods of use thereof

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009274482A1 (en) 2008-05-20 2010-01-28 Eos Neuroscience, Inc. Vectors for delivery of light-sensitive proteins and methods of use
EP2384220A2 (en) 2008-11-26 2011-11-09 Medtronic, Inc. Patient programmer with automated mri compatibility verification for active implantable medical device
CN101498723A (en) * 2009-02-27 2009-08-05 深圳先进技术研究院 Ion channel medicament screening apparatus and method
DE102009015389A1 (en) 2009-03-20 2010-09-30 Retina Implant Ag Active retinal implant for eye for serving to counteract loss of vision due to degenerations of retina, has array of stimulation elements that are designed as radiation-emitting elements
JP5719340B2 (en) * 2009-03-20 2015-05-20 レティーナ インプラント アーゲー Active retinal implant
US20110125078A1 (en) * 2009-11-25 2011-05-26 Medtronic, Inc. Optical stimulation therapy
US20130225664A1 (en) 2010-04-05 2013-08-29 Alan Horsager Methods and compositions for decreasing chronic pain
US20120253261A1 (en) * 2011-03-29 2012-10-04 Medtronic, Inc. Systems and methods for optogenetic modulation of cells within a patient
US10493297B2 (en) 2011-07-25 2019-12-03 Neuronexus Technologies, Inc. Neuromodulation transfection system with passive fluid delivery
EP2736406B1 (en) 2011-07-25 2019-09-04 NeuroNexus Technologies, Inc. Neuromodulation transfection system with means for active fluid delivery
US9782091B2 (en) 2011-07-25 2017-10-10 Neuronexus Technologies, Inc. Opto-electrical device for artifact reduction
US9199080B2 (en) 2011-09-12 2015-12-01 Okuvision Gmbh Method for treating an eye
US8868351B2 (en) 2011-10-13 2014-10-21 The Cleveland Clinic Foundation Estimation of neural response for optical stimulation
WO2014036170A1 (en) 2012-08-29 2014-03-06 Thync, Inc. Systems and devices for coupling ultrasound energy to a body
AU2019368519B2 (en) * 2018-10-26 2022-11-03 Shandong University System and method for real-time screening and measurement of cellular specific photosensitive effect
CN111690683A (en) * 2020-05-08 2020-09-22 天津大学 Design method of photosensitive protein plasmid sensitive to green light

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BROSENITCH ET AL.: "Physiological Patterns of Electrical Stimulation Can Induce Neuronal Gene Expressing by Activating N-Type Calcium Channels", J. OF NEUROSCIENCE, vol. 21, 2001, pages 2571 - 2579 *
SONG ET AL.: "Genes responsible for native depolarization-activated K+ currents in neurons", NEUROSCIENCE RES., vol. 42, 2002, pages 7 - 14 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858440B2 (en) 2008-07-14 2014-10-14 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and devices for modulating cellular activity using ultrasound
US9403038B2 (en) 2008-07-14 2016-08-02 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and devices for modulating cellular activity using ultrasound
US9042201B2 (en) 2011-10-21 2015-05-26 Thync, Inc. Method and system for direct communication
CN107531765B (en) * 2015-03-19 2021-07-16 得克萨斯州大学系统董事会 Compositions of anion channel rhodopsin and methods of use thereof

Also Published As

Publication number Publication date
WO2008089003A2 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
WO2008089003A3 (en) System for optical stimulation of target cells
Keppeler et al. Multichannel optogenetic stimulation of the auditory pathway using microfabricated LED cochlear implants in rodents
Bernstein et al. Optogenetic tools for analyzing the neural circuits of behavior
WO2012101494A3 (en) Systems and methods for detecting nerve stimulation with an implanted prosthesis
WO2007024391A3 (en) Light-activated cation channel and uses thereof
CN102283137A (en) Animal behaviour testing platform for optogenetics regulation and control
AU2012209095A8 (en) Combined stimulation with controlled light distribution for electro-optical cochlear implants
WO2011068696A3 (en) Neural probe with optical stimulation capability
Li et al. Single-cell mass spectrometry analysis of metabolites facilitated by cell electro-migration and electroporation
WO2010053673A3 (en) Implant electrode and accessories for use in robotic surgery
WO2007014134A3 (en) Tandem cardiac pacemaker system
Mao et al. Single-cell optogenetic control of calcium signaling with a high-density micro-LED array
CN107334471A (en) A kind of binary channels animal nerve unit signal record and synchronous stimulating system
Bi et al. A flexible, micro-lens-coupled LED stimulator for optical neuromodulation
Volman et al. Calcium and synaptic dynamics underlying reverberatory activity in neuronal networks
CN206964625U (en) A kind of binary channels animal nerve unit signal record and synchronous stimulating system
RU2010146628A (en) SYSTEM AND METHOD OF APOPTOSIS CHALLENGE IN MALIGNANT TUMOR CELLS FOR THE CONSERVATIVE TREATMENT
Hofmann et al. Light induced stimulation and delay of cardiac activity
Tillmaand et al. Peptidomics and secretomics of the mammalian peripheral sensory-motor system
Shoji et al. Diffusion refueling biofuel cell mountable on insect
CN102106722A (en) Photogene smell simulation system
Hasenhuetl et al. A half-centre oscillator encodes sleep pressure
Bi et al. Micro-lens-coupled LED neural stimulator for optogenetics
Kielar et al. Optogenetic Stimulation and Spatial Localization of Neurons Using a Multi-OLED Approach
US20220010279A1 (en) Kits and methods for performing optical dynamic clamp on excitable cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08727486

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08727486

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12522528

Country of ref document: US